NovaPoint Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
STMP
Stamps.com, Inc.
STMP
|
+$2.94M |
| 2 |
Vanguard Mid-Cap Value ETF
VOE
|
+$2.13M |
| 3 |
ProShares Short S&P500
SH
|
+$2.09M |
| 4 |
ProShares Short QQQ
PSQ
|
+$752K |
| 5 |
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
|
+$727K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.69M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.42M |
| 3 |
AbbVie
ABBV
|
+$1.62M |
| 4 |
ExxonMobil
XOM
|
+$1.24M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$433K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.84% |
| 2 | Financials | 9.73% |
| 3 | Consumer Discretionary | 8.58% |
| 4 | Healthcare | 6.09% |
| 5 | Consumer Staples | 6% |
Similar funds
NovaPoint Capital's Q3 2020 Portfolio in Review
As of Q3 2020, NovaPoint Capital held 107 positions worth $154M, up 15% from $134M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
NovaPoint Capital deployed $10.1M of net new capital in Q3 2020, opening 20 new positions and adding to 54 existing holdings. Its largest new stake was Vanguard Mid-Cap Value ETF: 21,059 shares worth $2.13M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $2.69M trimmed.
- NovaPoint Capital's largest Q3 2020 buy was Vanguard Mid-Cap Value ETF: 21,059 shares worth $2.13M.
- NovaPoint Capital added most to Stamps.com, Inc. in Q3 2020, an estimated $2.94M increase.
- NovaPoint Capital's biggest Q3 2020 reduction was Invesco QQQ Trust, cutting an estimated $2.69M.
- NovaPoint Capital fully exited AbbVie in Q3 2020, selling an estimated $1.62M.
- NovaPoint Capital's ten largest holdings make up 35% of its $154M portfolio in Q3 2020.
- NovaPoint Capital opened 20 new positions and closed 6 in Q3 2020.
- NovaPoint Capital's portfolio value rose 15% quarter-over-quarter to $154M.
Based on NovaPoint Capital's 13F filing for Q3 2020, filed 27 Oct 2020.